News
Onyx Scientific prepares for commercial API license with UK facility investment
Onyx Scientific has announced it is investing in a new facility at its UK site in order to prepare for the approval of a commercial API license.
The new facility, which represents a £3m investment, is currently in the design...
News
New RF Series Benchtop Bottle / Vial Filler Robot for Liquid Filling and Capping Operations
Dispense Works Inc. now offers the RF 2415 Robot that will streamline your filling and capping operations with one precise and affordable bench top package. This dispensing machine is able to process bottles, tubes, vials with caps screwed on...
News
New guidelines for independent batch control of COVID-19 vaccines by EU laboratories
Three new Official Control Authority Batch Release (OCABR) guidelines outlining the tests to be performed by the EU’s Official Medicines Control Laboratories (OMCLs) will be part of the independent control of COVID-19 vaccine batches, when they become available in...
Drug Research
Pioneering research potentially reveals early detection of prostate cancer
Pioneering research conducted by University of Virginia in collaboration with Manchester UK based APIS Assay Technologies Ltd has discovered Hormone-Upregulated lncRNA within the lymphocyte-specific protein tyrosine kinase (HULLK) is detectable in non-invasive prostate cancer patient samples.
The breakthrough data provides...
Drug Research
Ypsomed collaborates with SCHOTT and Lonza to develop a comprehensive solution for combination products based on patch injectors
Ypsomed advances its patch injector into a comprehensive solution by entering into a collaboration with SCHOTT, one of the leading suppliers of pharmaceutical primary packaging, and Lonza, a leading global partner of the pharmaceutical and biotechnology industry for the...
News
Pharmaceutical Supply Chains Ready to Manage the ‘Biggest Security Challenge for a generation’ as the World awaits new Covid Vaccine
Pharmaceutical supply chains are about to face their biggest security challenge for a generation as the world prepares for life-changing deliveries of Covid vaccines, says the Transported Asset Protection Association (TAPA).
An estimated 7-19 billion doses of the vaccine will...
News
Vibalogics establishes U.S. presence with virotherapy facility in Boston and plans to invest $150m
Vibalogics, a global contract development and manufacturing organization (CDMO), has today announced that it has initiated Phase I of its planned $150m investment in a late-phase clinical and commercial virotherapy manufacturing facility near Boston, Massachusetts.
The three-year investment plan includes...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















